Realseq
1 known investors
Find your way into Realseq
120 people in our graph share verified history with the Realseq team — schools, employers, funds. One of them is your warm intro.
Christine Samsunlockedknows Sergio Barberan-Soler · together at UC Santa Cruz (overlapped)
×11knows the team · via UC Santa Cruz
RealSeq Biosciences develops RNA fragmentomics technology for advanced diagnostics, enabling detection and analysis of RNA fragments to discover new biomarkers and provide deeper insights into disease. The company serves the healthcare and diagnostics industry by unlocking previously inaccessible biological information from RNA.
Founders & leadership
SB
Sergio Barberan-SolerinCo-founder and CEOSergio Barberan-Soler has over 20 years of experience in RNA biology and holds multiple patents; he is co-founder and CEO of RealSeq Biosciences, which develops RNA fragmentomics technology for disease diagnostics and biomarker discovery.
AS
Anne ScholzinCo-founder and COO
SK
Sergei KazakovinCo-founder and CSO
Investors · 1
Frequently asked questions
- What does Realseq do?
- RealSeq Biosciences develops RNA fragmentomics technology for advanced diagnostics, enabling detection and analysis of RNA fragments to discover new biomarkers and provide deeper insights into disease. The company serves the healthcare and diagnostics industry by unlocking previously inaccessible biological information from RNA.
- Who founded Realseq?
- Realseq was founded by Sergio Barberan-Soler, Anne Scholz, Sergei Kazakov.
- Who are Realseq's investors?
- Realseq's investors include Santa Cruz Venture.